| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS INC | A | C | $46.87B | 132,113,818 | 82.79% | 17.21% | Net Selling | Net Selling |
| CALX | CALIX INC | A | A | $3.71B | 66,276,473 | 77.47% | 22.53% | Net Selling | Net Selling |
| MYRG | MYR GROUP INC | A | C | $3.93B | 15,522,834 | 71.01% | 28.99% | Net Selling | Net Selling |
| TVTX | TRAVERE THERAPEUTICS INC | A | B | $2.69B | 89,472,327 | 63.49% | 36.51% | Net Selling | Net Selling |
| ARLO | ARLO TECHNOLOGIES INC | A | C | $1.40B | 105,992,268 | 96.29% | 3.71% | Net Selling | Net Selling |
| INNV | INNOVAGE HOLDING CORP | A | A | $781.53M | 135,681,431 | 4.58% | 95.42% | Net Selling | Net Selling |
| OPFI | OPPFI INC | A | B | $850.67M | 86,362,551 | 9.44% | 90.56% | Net Selling | Net Selling |
| AXGN | AXOGEN INC | A | A | $1.60B | 46,122,289 | 59.81% | 40.19% | Net Selling | Net Selling |
| ZDGE | ZEDGE INC | A | B | $42.28M | 13,010,106 | 18.37% | 20.19% | Net Selling | Net Buying |
| VREX | VAREX IMAGING CORP | A | A | $587.14M | 41,700,000 | 93.34% | 1.83% | Net Selling | Net Selling |
| ORGO | ORGANOGENESIS HOLDINGS INC | A | B | $506.38M | 126,912,142 | 6.93% | 93.07% | Net Selling | Net Selling |
| EHAB | ENHABIT INC | A | B | $525.30M | 50,607,075 | 96.09% | 3.91% | Net Buying | Net Selling |
| VISN | VISTANCE NETWORKS INC | A | B | $4.05B | 221,548,707 | 88.34% | 9.13% | Net Selling | Net Selling |
| TENB | TENABLE HOLDINGS INC | A | C | $2.72B | 119,344,266 | 67.66% | 32.34% | Net Selling | Net Selling |
| OPRX | OPTIMIZERX CORP | A | A | $219.40M | 18,640,652 | 52.15% | 47.85% | Net Buying | Net Selling |
| SHC | SOTERA HEALTH CO | A | A | $5.28B | 284,093,929 | 80.22% | 19.78% | Net Selling | Net Selling |
| TG | TREDEGAR CORP | A | C | $303.72M | 34,910,693 | 62.25% | 21.81% | Net Selling | Net Selling |
| CAH | CARDINAL HEALTH INC | A | A | $50.85B | 237,595,042 | 86.49% | 4.16% | Net Selling | Net Buying |
| BCRX | BIOCRYST PHARMACEUTICALS INC | A | B | $1.42B | 210,543,224 | 83.58% | 16.42% | Net Selling | Net Selling |
| ONC | BEONE MEDICINES LTD | A | B | $37.24B | 1,438,553,263 | 2.29% | 32.05% | Net Buying | Net Selling |
| CSTM | CONSTELLIUM SE | A | B | $3.13B | 137,801,779 | 93.26% | 0.97% | ||
| MIRM | MIRUM PHARMACEUTICALS INC | A | B | $5.10B | 51,393,574 | 52.20% | 47.80% | Net Buying | Net Buying |
| NATR | NATURES SUNSHINE PRODUCTS INC | A | A | $420.77M | 17,495,563 | 22.14% | 77.86% | Net Selling | Net Buying |
| OESX | ORION ENERGY SYSTEMS INC | A | B | $60.38M | 3,530,870 | 7.02% | 92.98% | Net Buying | Net Buying |
| ALNT | ALLIENT INC | A | B | $1.03B | 16,943,497 | 71.17% | 28.83% | Net Buying | Net Selling |
| AENT | ALLIANCE ENTERTAINMENT HOLDING CORP | A | A | $835.51M | 110,957,370 | 0.65% | 35.44% | Net Buying | |
| NVT | NVENT ELECTRIC PLC | A | B | $18.26B | 161,359,550 | 90.50% | 9.50% | Net Selling | Net Buying |
| ELAN | ELANCO ANIMAL HEALTH INC | A | C | $12.23B | 496,863,473 | 91.70% | 8.30% | Net Selling | Net Buying |
| HLMN | HILLMAN SOLUTIONS CORP | A | C | $1.88B | 197,289,638 | 92.81% | 7.19% | Net Buying | Net Selling |
| FMS | FRESENIUS MEDICAL CARE AG | A | B | $13.00B | 289,848,926 | 12.46% | 0.00% | ||
| ANIP | ANI PHARMACEUTICALS INC | A | B | $1.81B | 22,469,032 | 29.82% | 70.18% | Net Selling | Net Selling |
| MOG.A | MOOG INC | A | A | $9.11B | 31,676,836 | 87.63% | 3.91% | Net Selling | Net Selling |
| DAKT | DAKTRONICS INC | A | B | $1.07B | 48,747,817 | 71.81% | 27.11% | Net Buying | Net Buying |
| OOMA | OOMA INC | A | B | $338.38M | 27,600,000 | 69.63% | 24.77% | Net Selling | Net Selling |
| BCO | BRINKS CO | A | C | $5.21B | 41,545,506 | 81.04% | 18.96% | Net Selling | Net Selling |
| VVX | V2X INC | A | C | $2.17B | 31,535,083 | 94.53% | 5.47% | Net Selling | Net Selling |
| RSI | RUSH STREET INTERACTIVE INC | A | A | $3.92B | 229,412,772 | 26.81% | 73.19% | Net Selling | Net Buying |
| BTSG | BRIGHTSPRING HEALTH SERVICES INC | A | B | $7.04B | 180,352,297 | 54.66% | 45.34% | Net Selling | Net Selling |
| FRD | FRIEDMAN INDUSTRIES INC | A | C | $132.86M | 7,112,182 | 53.21% | 15.55% | Net Buying | Net Buying |
| BSBR | BANCO SANTANDER (BRASIL) SA | A | B | $52.96B | 7,459,627,927 | 7.19% | 0.00% | ||
| DLX | DELUXE CORP | A | B | $1.10B | 45,007,664 | 84.37% | 4.98% | Net Selling | Net Selling |
| AMX | AMERICA MOVIL SAB DE CV | A | D | $64.36B | 61,000,000,000 | 0.31% | 0.00% | ||
| PAHC | PHIBRO ANIMAL HEALTH CORP | A | B | $1.60B | 40,533,608 | 43.60% | 56.40% | Net Selling | Net Selling |
| RNG | RINGCENTRAL INC | A | C | $2.34B | 86,564,715 | 89.15% | 10.85% | Net Selling | Net Selling |
| NMRK | NEWMARK GROUP INC | A | C | $3.10B | 180,412,407 | 62.68% | 30.68% | Net Selling | |
| PCRX | PACIRA BIOSCIENCES INC | A | C | $853.97M | 43,021,275 | 67.55% | 32.45% | Net Selling | Net Selling |
| HCI | HCI GROUP INC | A | B | $1.97B | 12,960,037 | 78.69% | 9.80% | Net Selling | |
| EXTR | EXTREME NETWORKS INC | A | C | $1.97B | 133,718,479 | 82.39% | 17.61% | Net Selling | Net Selling |
| KALU | KAISER ALUMINUM CORP | A | B | $1.99B | 16,206,255 | 95.96% | 3.19% | Net Selling | Net Selling |
| VRRM | VERRA MOBILITY CORP | A | C | $3.20B | 159,564,447 | 88.96% | 11.04% | Net Selling | Net Selling |
| COHN | COHEN & CO INC | A | C | $35.67M | 2,035,863 | 0.32% | 99.68% | Net Selling | |
| KRMD | KORU MEDICAL SYSTEMS INC | A | A | $263.11M | 46,322,655 | 43.42% | 33.49% | Net Buying | Net Buying |
| CMC | COMMERCIAL METALS CO | A | C | $8.48B | 110,907,418 | 91.12% | 8.88% | Net Selling | Net Buying |
| DOO | BRP INC | A | A | $5.84B | 73,354,347 | 40.98% | 0.00% | ||
| RERE | ATRENEW INC | A | B | $625.46M | 161,397,323 | 32.50% | 0.00% | ||
| MATV | MATIV HOLDINGS INC | A | A | $684.06M | 54,681,114 | 89.94% | 9.28% | Net Selling | Net Selling |
| CYD | CHINA YUCHAI INTERNATIONAL LTD | A | A | $1.79B | 37,518,322 | 18.38% | 0.00% | ||
| RAMP | LIVERAMP HOLDINGS INC | A | A | $1.60B | 63,648,844 | 54.89% | 45.11% | Net Selling | Net Selling |
| INDV | INDIVIOR PLC | A | A | $4.34B | 124,853,897 | 99.85% | 0.15% | Net Buying | Net Buying |
| MU | MICRON TECHNOLOGY INC | A | A | $461.73B | 1,125,509,261 | 77.02% | 1.59% | Net Selling | Net Selling |
| DBD | DIEBOLD NIXDORF INC | A | A | $2.44B | 35,867,156 | 84.16% | 15.84% | Net Selling | Net Selling |
| NVST | ENVISTA HOLDINGS CORP | A | B | $3.96B | 164,426,233 | 63.78% | 36.22% | Net Selling | Net Selling |
| GMED | GLOBUS MEDICAL INC | A | A | $12.31B | 133,839,166 | 78.85% | 21.15% | Net Buying | Net Buying |
| STRT | STRATTEC SECURITY CORP | A | A | $329.92M | 4,185,271 | 78.74% | 19.60% | Net Selling | Net Selling |
| MG | MISTRAS GROUP INC | A | B | $443.25M | 31,548,153 | 50.45% | 37.22% | Net Buying | Net Selling |
| AVAH | AVEANNA HEALTHCARE HOLDINGS INC | A | A | $1.74B | 208,911,383 | 24.82% | 75.18% | Net Selling | Net Selling |
| TBLA | TABOOLACOM LTD | A | A | $1.19B | 288,223,366 | 29.76% | 28.27% | Net Selling | Net Selling |
| MDXG | MIMEDX GROUP INC | A | B | $784.94M | 148,102,159 | 46.43% | 53.57% | Net Buying | Net Selling |
| FIVN | FIVE9 INC | A | C | $1.44B | 78,216,052 | 71.46% | 28.54% | Net Selling | Net Selling |
| BGC | BGC GROUP INC | A | C | $4.15B | 468,747,805 | 40.37% | 59.63% | Net Buying | Net Selling |
| LE | LANDS' END INC | A | B | $585.05M | 30,551,068 | 13.36% | 86.64% | Net Selling | Net Selling |
| APTV | APTIV PLC | A | A | $16.86B | 216,079,411 | 80.27% | 19.73% | Net Selling | Net Selling |
| ORLA | ORLA MINING LTD | A | C | $6.35B | 337,560,000 | 61.93% | 0.00% | ||
| COLL | COLLEGIUM PHARMACEUTICAL INC | A | C | $1.43B | 31,610,976 | 51.95% | 48.05% | Net Selling | Net Selling |
| KN | KNOWLES CORP | A | B | $2.06B | 85,151,884 | 96.72% | 3.28% | Net Selling | Net Selling |
| MCFT | MASTERCRAFT BOAT HOLDINGS INC | A | B | $347.60M | 16,288,798 | 39.19% | 60.81% | Net Buying | Net Buying |
| PPIH | PERMA-PIPE INTERNATIONAL HOLDINGS INC | A | B | $243.63M | 8,094,045 | 43.01% | 33.25% | Net Selling | |
| AMRX | AMNEAL PHARMACEUTICALS INC | A | C | $4.35B | 314,362,920 | 28.65% | 71.35% | Net Selling | Net Selling |
| DY | DYCOM INDUSTRIES INC | A | B | $10.85B | 28,956,051 | 94.02% | 5.98% | Net Selling | Net Selling |
| CION | CION INVESTMENT CORP | A | B | $482.61M | 51,670,947 | 37.01% | 0.84% | Net Buying | |
| MGA | MAGNA INTERNATIONAL INC | A | B | $15.09B | 281,814,257 | 65.04% | 0.00% | ||
| PRLB | PROTO LABS INC | A | B | $1.24B | 23,678,745 | 65.78% | 34.22% | Net Selling | Net Buying |
| STN | STANTEC INC | A | C | $11.51B | 114,066,995 | 56.90% | 0.00% | ||
| TBRG | TRUBRIDGE INC | A | C | $306.93M | 15,008,986 | 27.50% | 72.50% | Net Buying | Net Buying |
| PTC | PTC INC | A | C | $19.66B | 119,448,261 | 80.01% | 19.99% | Net Selling | Net Selling |
| EGHT | 8X8 INC | A | B | $235.69M | 138,640,363 | 70.05% | 29.95% | Net Selling | Net Selling |
| CGAU | CENTERRA GOLD INC | A | B | $3.94B | 201,642,438 | 68.30% | 0.00% | ||
| VRT | VERTIV HOLDINGS CO | A | B | $72.34B | 382,338,313 | 78.25% | 12.12% | Net Selling | Net Buying |
| EWCZ | EUROPEAN WAX CENTER INC | A | A | $216.90M | 54,360,321 | 36.56% | 63.44% | Net Selling | Net Selling |
| GNE | GENIE ENERGY LTD | A | C | $377.55M | 26,494,954 | 37.01% | 47.37% | Net Selling | Net Buying |
| LTM | LATAM AIRLINES GROUP SA | A | A | $40.17B | 604,437,877,587 | 0.01% | 0.00% | ||
| BMY | BRISTOL MYERS SQUIBB CO | A | C | $113.11B | 2,035,753,027 | 77.56% | 0.37% | Net Selling | Net Selling |
| VCYT | VERACYTE INC | A | A | $3.15B | 79,049,173 | 67.83% | 32.17% | Net Selling | Net Selling |
| BCIC | BCP INVESTMENT CORP | A | B | $162.34M | 13,081,251 | 11.43% | 88.57% | Net Buying | Net Buying |
| GRFS | GRIFOLS SA | A | C | $6.39B | 687,554,908 | 20.38% | 0.00% | ||
| KE | KIMBALL ELECTRONICS INC | A | A | $722.36M | 24,338,363 | 80.73% | 7.45% | Net Selling | Net Buying |
| GRDN | GUARDIAN PHARMACY SERVICES INC | A | B | $2.16B | 72,623,011 | 27.09% | 43.69% | Net Selling | Net Buying |
| UAN | CVR PARTNERS LP | A | C | $1.10B | 10,569,637 | 7.59% | 92.41% | Net Buying | Net Selling |
| JAZZ | JAZZ PHARMACEUTICALS PLC | A | C | $10.20B | 60,765,116 | 28.42% | 71.58% | Net Selling | Net Selling |
| MAX | MEDIAALPHA INC | A | B | $698.64M | 65,171,840 | 45.72% | 54.28% | Net Selling | Net Selling |
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
It’s little wonder that growth stocks have a reputation as exciting, high-reward investing opportunities. After all, some of the most successful stocks — think Amazon (NASDAQ: AMZN), Tesla (NASDAQ: TSLA), and Nvidia (NASDAQ: NVDA) — started as growth stocks.
However, not every stock experiencing rapid development will go on to dominate the stock market. The potential for high rewards comes with increased risk. A company showing high revenue growth doesn’t necessarily equal a great investment.
Keep reading to learn:
A growth stock is a company whose revenue, earnings, or market share is expanding at a significantly faster rate than the market average or its industry peers.
Companies that prioritize rapid revenue and earnings growth often reinvest profits instead of paying dividends, betting their money on expansion, innovation, and market dominance.
In the stock market, a security's success can last for minutes — or decades. How can you tell the difference between a stock that's portfolio-worthy for the long haul versus one fueled by temporary market hype?
True growth stocks typically have strong fundamentals, such as consistent revenue growth, expanding profit margins, and a competitive edge (for example, proprietary technology or brand dominance). They also have a scalable business model and demonstrate resilience across market cycles, such as during periods of high interest rates or other major economic events.
In contrast, stocks driven by temporary market trends — say, meme stocks or companies capitalizing on short-lived trends — often rely on speculative momentum but lack solid financials and struggle to sustain growth once the fad fades. The decline can happen fast — for instance, a company that was killing it in the fourth quarter could report a net loss by their next earnings report.
Here are some characteristics to look for before you buy:
Perhaps the biggest misconception in growth investing is that the best way to generate fast returns is to buy shares of the fastest-growing companies.
In reality, stocks with the highest projected growth rates tend to deliver the worst stock price performance. At first glance, this might seem like a strange concept, so let’s break it down.
When a company is expected to grow earnings by 30%+ per year, its stock experiences a surge in price, often experiencing a powerful period of price appreciation. But it is often unsustainable.
Why? Because the competition takes notice, adapts, and fights to gain market share. Maintaining that pace becomes nearly impossible.
Even if a company’s growth slows from 30% to a still-impressive 20%, it can be catastrophic for the stock if investors and analysts pricing it for higher expectations. The moment those investors and analysts realize the period of extreme growth is over, you can safely expect them to move on — and the stock price can collapse.
So, if you shouldn't buy solely based on rapid expansion and price action, what should you look for? Consistent, sustainable growth.
As for how to identify it…
Identifying stocks with growth potential requires a combination of research, analysis, and due diligence.
Our Best Stocks to Buy Now for High Growth screener can help you easily focus on stocks with a high Zen Rating for Growth.
As part of its overall 115-factor review of the 4600+ stocks we track, our quant model assesses 21 different measures of Growth. It considers sales and earnings growth, but it also looks for gains in revenue, cash flow, profit margins, and EBITDA to ensure that companies with strong or underrated growth prospects make the cut.
After all, the more consistent these gains, particularly across multiple growth measures, the more likely the stock's price will continue to appreciate.
However, that doesn’t tell the whole story. That’s why it’s important to take a big-picture view.
This may sound counterintuitive, but when looking for high-quality growth stocks to buy, it’s worth considering more than just growth, such as:
Zen Ratings can help you gain this type of bigger-picture view. In addition to reviewing 22 Growth Factors, it also zeroes in on 93 other Factors that can greatly increase the likelihood of outperforming the market, including 21 Value Factors, 26 Financial Factors, and more.
Locating the best growth stocks isn’t just about locating the most impressive price action in the market.
Our Best Growth Stocks to Buy Now screener can help you quickly locate stocks to buy, but it’s important to remember that growth doesn’t exist in a vacuum — you must consider the big picture.
Growth-oriented investors should seek stocks that display an overall A or B rating while also scoring A or B for Growth. However, you should also consider other factors that may support growth, such as Financials, Momentum, and Sentiment.
If you're looking for guidance in choosing high-quality stocks, consider becoming a Zen Investor member. The portfolio includes hand-picked stocks that have passed a rigorous screening process that considers criteria like valuation, performance, what analysts are saying, and more. Save time and energy — Gain access to the market-beating Zen Investor portfolio now.